$AYTU News

Elite Pharmaceuticals vs. Aytu: Which CNS Stock Is the Better Buy?

Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $15

Aytu BioPharma, Inc. Q4 2026 Earnings Call Summary

Aytu BioPharma Inc (AYTU) (Q4 2026) Earnings Call Highlights: EXXUA Launch Accelerates as ...

Aytu BioPharma, Inc. (AYTU) Reports Q4 Loss, Beats Revenue Estimates

Aytu BioPharma Inc. (NASDAQ:AYTU) Shares Jump 125% on Q4 Beat and Strong EXXUA Launch

Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results

Aytu BioPharma, Inc. (AYTU) Q4 2026 Earnings Call Transcript

Transcript: Aytu BioPharma Q4 2026 Earnings Conference Call

Aytu BioPharma Q4 EPS $0.00 and Sales $16.106M Beat $12.276M Estimate

Aytu BioPharma to Report Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results on September 22, 2026

Aytu BioPharma And And Lannett Terminate Metadate Agreement Effective June 23, 2026; Co. To Continue Selling Existing Metadate Inventory And Pay Royalties Until Sales Cease

Ascendiant Capital Maintains Buy on Aytu BioPharma, Raises Price Target to $14.5

Aytu BioPharma to Present at the Planet MicroCap Las Vegas 2026 Investor Conference on June 17, 2026

Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026

Aytu BioPharma, Inc. Q3 2026 Earnings Call Summary

Aytu BioPharma Inc (AYTU) Q3 2026 Earnings Call Highlights: Strong Exua Adoption Amid Revenue ...

Aytu (AYTU) Q3 2026 Earnings Transcript

Full Transcript: Aytu BioPharma Q3 2026 Earnings Call

Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call Transcript